Citation 83397

HATANO,T: UEBAYASHI,H: ITO,H: SHIOTA,S: SSUCHIYA,T: YOSHIDA,T:. (1999). PHENOLIC CONSTITUENTS OF CASSIA SEEDS AND ANTIBACTERIAL EFFECT OF SOME NAPHTHALENES AND ANTHRAQUINONES ON METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS.. 47(8)

Citation Details

Title	PHENOLIC CONSTITUENTS OF CASSIA SEEDS AND ANTIBACTERIAL EFFECT OF SOME NAPHTHALENES AND ANTHRAQUINONES ON METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS.
Authors	HATANO,T: UEBAYASHI,H: ITO,H: SHIOTA,S: SSUCHIYA,T: YOSHIDA,T:
Year	1999
Volume	47
Issue	8

Summary

Year: 1999

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORACHRYSONE	ACTIVE
2	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORACHRYSONE	INACTIVE
3	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORACHRYSONE	ACTIVE
4	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORACHRYSONE	ACTIVE
5	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORACHRYSONE	ACTIVE
6	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORACHRYSONE	ACTIVE
7	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORACHRYSONE	ACTIVE
8	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSOPHANIC ACID	WEAK ACTIVITY
9	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSOPHANIC ACID	INACTIVE
10	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSOPHANIC ACID	ACTIVE
11	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSOPHANIC ACID	ACTIVE
12	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSOPHANIC ACID	ACTIVE
13	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSOPHANIC ACID	ACTIVE
14	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSOPHANIC ACID	ACTIVE
15	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ALOE EMODIN	INACTIVE
16	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ALOE EMODIN	INACTIVE
17	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ALOE EMODIN	STRONG ACTIVITY
18	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ALOE EMODIN	STRONG ACTIVITY
19	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ALOE EMODIN	STRONG ACTIVITY
20	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ALOE EMODIN	STRONG ACTIVITY
21	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ALOE EMODIN	STRONG ACTIVITY
22	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RHEIN	ACTIVE
23	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RHEIN	INACTIVE
24	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RHEIN	ACTIVE
25	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RHEIN	ACTIVE
26	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RHEIN	ACTIVE
27	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RHEIN	ACTIVE
28	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RHEIN	ACTIVE

Cassia tora (FABACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA	RUBROFUSARIN GENTIOBIOSIDE	None
2	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RUBROFUSARIN GENTIOBIOSIDE	INACTIVE
3	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RUBROFUSARIN GENTIOBIOSIDE	INACTIVE
4	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RUBROFUSARIN GENTIOBIOSIDE	INACTIVE
5	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RUBROFUSARIN GENTIOBIOSIDE	INACTIVE
6	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RUBROFUSARIN GENTIOBIOSIDE	INACTIVE
7	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RUBROFUSARIN GENTIOBIOSIDE	INACTIVE
8	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RUBROFUSARIN GENTIOBIOSIDE	INACTIVE
9	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CASSIASIDE C	None
10	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CASSIASIDE C	INACTIVE
11	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CASSIASIDE C	INACTIVE
12	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CASSIASIDE C	INACTIVE
13	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CASSIASIDE C	INACTIVE
14	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CASSIASIDE C	INACTIVE
15	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CASSIASIDE C	INACTIVE
16	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CASSIASIDE C	INACTIVE
17	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CHRYSOPHANIC ACID TETRAGLUCOSIDE	None
18	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSOPHANIC ACID TETRAGLUCOSIDE	INACTIVE
19	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSOPHANIC ACID TETRAGLUCOSIDE	INACTIVE
20	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSOPHANIC ACID TETRAGLUCOSIDE	INACTIVE
21	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSOPHANIC ACID TETRAGLUCOSIDE	INACTIVE
22	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSOPHANIC ACID TETRAGLUCOSIDE	ACTIVE
23	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSOPHANIC ACID TETRAGLUCOSIDE	ACTIVE
24	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSOPHANIC ACID TETRAGLUCOSIDE	INACTIVE
25	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	RUBROFUSARIN TRIGLUCOSIDE	None
26	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RUBROFUSARIN TRIGLUCOSIDE	INACTIVE
27	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RUBROFUSARIN TRIGLUCOSIDE	ACTIVE
28	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RUBROFUSARIN TRIGLUCOSIDE	ACTIVE
29	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RUBROFUSARIN TRIGLUCOSIDE	INACTIVE
30	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RUBROFUSARIN TRIGLUCOSIDE	INACTIVE
31	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RUBROFUSARIN TRIGLUCOSIDE	INACTIVE
32	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RUBROFUSARIN TRIGLUCOSIDE	INACTIVE
33	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TORACHRYSONE GENTIOBIOSIDE	None
34	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORACHRYSONE GENTIOBIOSIDE	INACTIVE
35	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORACHRYSONE GENTIOBIOSIDE	INACTIVE
36	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORACHRYSONE GENTIOBIOSIDE	INACTIVE
37	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORACHRYSONE GENTIOBIOSIDE	INACTIVE
38	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORACHRYSONE GENTIOBIOSIDE	INACTIVE
39	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORACHRYSONE GENTIOBIOSIDE	INACTIVE
40	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORACHRYSONE GENTIOBIOSIDE	INACTIVE
41	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TORACHRYSONE TETRAGLUCOSIDE	None
42	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORACHRYSONE TETRAGLUCOSIDE	INACTIVE
43	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORACHRYSONE TETRAGLUCOSIDE	INACTIVE
44	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORACHRYSONE TETRAGLUCOSIDE	INACTIVE
45	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORACHRYSONE TETRAGLUCOSIDE	INACTIVE
46	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORACHRYSONE TETRAGLUCOSIDE	INACTIVE
47	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORACHRYSONE TETRAGLUCOSIDE	INACTIVE
48	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORACHRYSONE TETRAGLUCOSIDE	INACTIVE
49	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	RUBROFUSARIN	None
50	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RUBROFUSARIN	WEAK ACTIVITY
51	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RUBROFUSARIN	INACTIVE
52	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RUBROFUSARIN	ACTIVE
53	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RUBROFUSARIN	ACTIVE
54	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RUBROFUSARIN	ACTIVE
55	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RUBROFUSARIN	ACTIVE
56	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RUBROFUSARIN	ACTIVE
57	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	EMODIN	None
58	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	EMODIN	INACTIVE
59	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	EMODIN	INACTIVE
60	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	EMODIN	ACTIVE
61	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	EMODIN	ACTIVE
62	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	EMODIN	ACTIVE
63	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	EMODIN	ACTIVE
64	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	EMODIN	ACTIVE
65	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	PHYSCION	None
66	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PHYSCION	INACTIVE
67	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PHYSCION	INACTIVE
68	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PHYSCION	INACTIVE
69	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PHYSCION	INACTIVE
70	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PHYSCION	INACTIVE
71	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PHYSCION	INACTIVE
72	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PHYSCION	INACTIVE
73	Not specified	ISOLATION AND IDENTIFICATION OFIDENTIFICATION IN AFTER ACID HYDROLYSIS	TORALACTONE	None
74	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORALACTONE	INACTIVE
75	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORALACTONE	INACTIVE
76	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORALACTONE	ACTIVE
77	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORALACTONE	ACTIVE
78	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORALACTONE	ACTIVE
79	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORALACTONE	ACTIVE
80	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORALACTONE	ACTIVE
81	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CASSIASIDE	None
82	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	TOROSACHRYSONE GENTIOBIOSIDE	None
83	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CASSIASIDE C-2	None
84	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	RUBROFUSARIN TETRAGLUCOSIDE	None
85	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	RUBROFUSARIN,NOR: GENTIOBIOSIDE	None
86	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	FLAVASPERONE,DEMETHYL: GENTIOBIOSIDE:	None
87	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TORACHRYSONE APIOGLUCOSIDE	None